Acute hepatitis C infection: Can immunology teach us the right way to treat?
- 1 November 2004
- journal article
- research article
- Published by Springer Nature in Current Hepatitis Reports
- Vol. 3 (4) , 148-156
- https://doi.org/10.1007/s11901-004-0025-6
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3*1, *2Journal of Hepatology, 2004
- 36 Induction of hepatitis C virus specific T cells by needle stick injury in the absence of HCV-viremiaHepatology, 2003
- HCV Persistence and Immune Evasion in the Absence of Memory T Cell HelpScience, 2003
- Treatment of Acute Hepatitis C with Interferon Alfa-2bNew England Journal of Medicine, 2001
- Hepatitis C Virus: An Important Occupational Hazard?Occupational Medicine, 2000
- Association of Hepatitis C Virus–Specific CD8+T Cells with Viral Clearance in Acute Hepatitis CThe Journal of Infectious Diseases, 2000
- The Outcome of Acute Hepatitis C Predicted by the Evolution of the Viral QuasispeciesScience, 2000
- High-dose interferon-α2b treatment prevents chronicity in acute hepatitis CDigestive Diseases and Sciences, 1996
- A randomized controlled trial of recombinant interferon α-2b in the treatment of Chinese patients with acute post-transfusion hepatitis CJournal of Hepatology, 1994
- Effects of interferon beta on non-A, non-B acute hepatitis: A prospective, randomized, controlled-dose studyGastroenterology, 1994